Examples of using Use in children in English and their translations into Slovenian
{-}
- 
                        Medicine
                    
- 
                        Colloquial
                    
- 
                        Official
                    
- 
                        Ecclesiastic
                    
- 
                        Financial
                    
- 
                        Computer
                    
- 
                        Official/political
                    
- 
                        Programming
                    
INCIVO is not for use in children or adolescents, because it has not been sufficiently studied in  patients under 18 years of age.
Cinacalcet is not indicated for use in children and adolescents due to a lack of data on safety and efficacy(see section 5.2).
Benepali is not for use in children, as Benepali does not have low-dose formulations.
Use in children and adolescents under the age of 18 years:
Mimpara is not indicated for use in children and adolescents due to a lack of data on safety and efficacy(see section 4.4).
Use in children from 6 to 12 months is possible only according to the doctor's prescription and under strict medical supervision.
DuoPlavin is not intended for use in children or adolescents less than 18 years of age.
Olanzapine is not recommended for use in children and adolescents below 18 years of age due to a lack of data on safety and efficacy.
Use in children and adolescents under 18 years of age DULOXETINE BOEHRINGER INGELHEIM should not be used  for children 
This medication has not been approved for use in children, as it has not been adequately studied in  individuals younger than 18 years of age.
Use in children and adolescents under 18 years of age DULOXETINE BOEHRINGER INGELHEIM should normally not be used  for children  and adolescents under 18 years.
The educational materials also include a reminder that Benepali is not for use in children.
Use in children(2 years of age
Therefore it is proposed to extend the ten-year period of orphan market exclusivity to twelve-years if the requirements for data on use in children are fully met.
Existing information on the pharmaceutical product does not adequately ensure safe and effective use in children(3);
Kaletra is not recommended for use in children less than 2 years of age because of limited efficacy and safety data.
for systemic use in children up to 12 years,
Dosages: Sudafed-(Never use in children under the age of 4)
Use in children with breathing problems Codeine is not recommended in children  with breathing problems, since the symptoms of morphine toxicity may be worse in  these children. .
Many of these medications used  for treating autism may have not been officially approved by the FDA for use in children, but the doctor prescribes them if he